Ulla Hass
Overview
Explore the profile of Ulla Hass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1616
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Solecki R, Kortenkamp A, Bergman A, Chahoud I, Degen G, Dietrich D, et al.
Arch Toxicol
. 2016 Oct;
91(2):1001-1006.
PMID: 27714423
Endocrine disruption is a specific form of toxicity, where natural and/or anthropogenic chemicals, known as "endocrine disruptors" (EDs), trigger adverse health effects by disrupting the endogenous hormone system. There is...
12.
Boberg J, Christiansen S, Axelstad M, Kledal T, Vinggaard A, Dalgaard M, et al.
Reprod Toxicol
. 2016 Aug;
63:183-184.
PMID: 27523804
No abstract available.
13.
Vandenberg L, Agerstrand M, Beronius A, Beausoleil C, Bergman A, Bero L, et al.
Environ Health
. 2016 Jul;
15(1):74.
PMID: 27412149
Background: The issue of endocrine disrupting chemicals (EDCs) is receiving wide attention from both the scientific and regulatory communities. Recent analyses of the EDC literature have been criticized for failing...
14.
Johansson H, Jacobsen P, Hass U, Svingen T, Vinggaard A, Isling L, et al.
Reprod Toxicol
. 2016 Apr;
61:186-94.
PMID: 27049580
Exposure to endocrine disrupting chemicals (EDCs) during development can have negative consequences later in life. In this study we investigated the effect of perinatal exposure to mixtures of human relevant...
15.
Svingen T, Letting H, Hadrup N, Hass U, Vinggaard A
PeerJ
. 2015 Apr;
3:e855.
PMID: 25825680
In biological research the analysis of gene expression levels in cells and tissues can be a powerful tool to gain insights into biological processes. For this, quantitative RT-PCR (RT-qPCR) is...
16.
Hauser R, Skakkebaek N, Hass U, Toppari J, Juul A, Andersson A, et al.
J Clin Endocrinol Metab
. 2015 Mar;
100(4):1267-77.
PMID: 25742517
Introduction: Increasing evidence suggests that endocrine-disrupting chemicals (EDCs) contribute to male reproductive diseases and disorders. Purpose: To estimate the incidence/prevalence of selected male reproductive disorders/diseases and associated economic costs that...
17.
Trasande L, Zoeller R, Hass U, Kortenkamp A, Grandjean P, Myers J, et al.
J Clin Endocrinol Metab
. 2015 Mar;
100(4):1245-55.
PMID: 25742516
Context: Rapidly increasing evidence has documented that endocrine-disrupting chemicals (EDCs) contribute substantially to disease and disability. Objective: The objective was to quantify a range of health and economic costs that...
18.
Lichtensteiger W, Bassetti-Gaille C, Faass O, Axelstad M, Boberg J, Christiansen S, et al.
Endocrinology
. 2015 Jan;
156(4):1477-93.
PMID: 25607892
The study addressed the question whether gene expression patterns induced by different mixtures of endocrine disrupting chemicals (EDCs) administered in a higher dose range, corresponding to 450×, 200×, and 100×...
19.
Hadrup N, Pedersen M, Skov K, Lund Hansen N, Berthelsen L, Kongsbak K, et al.
Arch Toxicol
. 2015 Jan;
90(3):661-75.
PMID: 25588985
Humans are simultaneously exposed to several chemicals that act jointly to induce mixture effects. At doses close to or higher than no-observed adverse effect levels, chemicals usually act additively in...
20.
Boberg J, Johansson H, Hadrup N, Dreisig K, Berthelsen L, Almstrup K, et al.
Prostate
. 2014 Oct;
75(2):126-40.
PMID: 25327291
Background: Elevated levels of endogenous or exogenous estrogens during fetal life can induce permanent disturbances in prostate growth and predispose to precancerous lesions. Recent studies have indicated that also early...